In summary, our study explored the mechanisms of DDR signaling communicating with the IRF1 pathway in regulating the HCC tumor microenvironment and can potentially serve as a therapeutic strategy in treating patients with advanced HCC. This evidence concerns the gene IRF1 and neoplasm.